Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06658847 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive Measurements

A NA study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT06658847 is a NA study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06658847, a NA study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

This study is being conducted to confirm whether skin tape stripping methodology can identify changes in gene expression (i.e. whether different genes are turned on to make proteins) in aged skin after use of a retinoid.

Interventions

  • OTHER Night Cream Usage
  • OTHER No Night Cream Usage

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2024-11-07
Est. Completion 2025-04-29
Phase NA

What the Registry Record Tells You About NCT06658847

The ClinicalTrials.gov registry entry for NCT06658847 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Night Cream Usage is the first listed.

NCT06658847 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06658847 about?

NCT06658847 is a clinical study titled "A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive Measurements". This study is being conducted to confirm whether skin tape stripping methodology can identify changes in gene expression (i.e. whether different genes are turned on to make proteins) in aged skin after use of a retinoid.

What is the current status of trial NCT06658847?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2024-11-07. Estimated completion is 2025-04-29.

What interventions are being tested in trial NCT06658847?

The interventions under investigation include: Night Cream Usage (OTHER), No Night Cream Usage (OTHER).

Who is sponsoring clinical trial NCT06658847?

This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.